Made in the USA, a new daily oral weight-loss pill from Eli Lilly won't require cold storage and is expected to hit markets ...

Shares of Eli Lilly soared Thursday morning after the pharmaceutical giant announced a clinical trial of its once-daily ...

The drug is still going through trials, but the medical company Lilly, behind it, is hopeful it can be rolled out soon. In ...

Diabetics given the pill called orforglipron lost 16 pounds, or 7.9% of their body weight, over a 40-week period.

Researchers at Mass General Brigham found that by December 2023, over one-third of all new prescriptions for type 2 diabetes ...

It's little secret that America has a weight problem. For decades, Americans have embraced and abandoned countless ...

But this one, for Lilly’s first diabetes and weight-loss pill based on the GLP-1 hormone, was particularly fraught. Days ...

Tirzepatide is approved for 3 indications in the US: type 2 diabetes, chronic weight management, and obstructive sleep apnea.

Novo Nordisk will pay as much as $2 billion for a new obesity drug called ... expand its lineup of advanced weight-loss treatments. Although the company’s drugs have been popular, trials ...

A decision by CMS to not move forward with a proposed rule allowing obesity medications to be covered under Medicare Part D ...

People are buying semaglutide and tirzepatide, the key ingredients in Ozempic and Zepbound, from unconventional sources. Doctors have safety concerns.

Kapil Sharma stunned fans with his noticeably slimmer look at the Mumbai airport, sparking weight loss speculations. While some linked his transformation to intense workouts, others guessed the use of ...